These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19698816

  • 1. Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
    Archer DF, Kovalevsky G, Ballagh SA, Grubb GS.
    Contraception; 2009 Sep; 80(3):245-53. PubMed ID: 19698816
    [Abstract] [Full Text] [Related]

  • 2. Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
    Seidman L, Kroll R, Howard B, Ricciotti N, Hsieh J, Weiss H.
    Contraception; 2015 Jun; 91(6):495-502. PubMed ID: 25746294
    [Abstract] [Full Text] [Related]

  • 3. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS.
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [Abstract] [Full Text] [Related]

  • 4. A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation.
    Kroll R, Seidman L, Ricciotti N, Howard B, Weiss H.
    Eur J Contracept Reprod Health Care; 2015 Jan; 20(4):249-58. PubMed ID: 25522805
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.
    Vandever MA, Kuehl TJ, Sulak PJ, Witt I, Coffee A, Wincek TJ, Reape KZ.
    Contraception; 2008 Mar; 77(3):162-70. PubMed ID: 18279685
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.
    Duijkers IJ, Klipping C, Zimmerman Y, Appels N, Jost M, Maillard C, Mawet M, Foidart JM, Coelingh Bennink HJ.
    Eur J Contracept Reprod Health Care; 2015 Mar; 20(6):476-89. PubMed ID: 26394847
    [Abstract] [Full Text] [Related]

  • 7. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J, Elstein M, Feichtinger W, Sullivan H, Lüdicke F, Müller U, Düsterberg B.
    Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
    [Abstract] [Full Text] [Related]

  • 8. Ovarian activity during regular oral contraceptive use.
    Crosignani PG, Testa G, Vegetti W, Parazzini F.
    Contraception; 1996 Nov; 54(5):271-3. PubMed ID: 8934059
    [Abstract] [Full Text] [Related]

  • 9. Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles.
    Westhoff CL, Reinecke I, Bangerter K, Merz M.
    Contraception; 2014 Sep; 90(3):272-9. PubMed ID: 24969733
    [Abstract] [Full Text] [Related]

  • 10. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
    Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D.
    Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
    [Abstract] [Full Text] [Related]

  • 11. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment.
    Elomaa K, Lähteenmäki P.
    Contraception; 1999 Nov; 60(5):275-9. PubMed ID: 10717779
    [Abstract] [Full Text] [Related]

  • 12. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles.
    Landgren BM, Diczfalusy E.
    Contraception; 1984 May; 29(5):437-46. PubMed ID: 6430642
    [Abstract] [Full Text] [Related]

  • 13. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate.
    Rible RD, Taylor D, Wilson ML, Stanczyk FZ, Mishell DR.
    Contraception; 2009 Mar; 79(3):182-8. PubMed ID: 19185670
    [Abstract] [Full Text] [Related]

  • 14. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Spona J, Feichtinger W, Kindermann C, Moore C, Mellinger U, Walter F, Gräser T.
    Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211
    [Abstract] [Full Text] [Related]

  • 15. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol.
    Creinin MD, Lippman JS, Eder SE, Godwin AJ, Olson W.
    Contraception; 2002 Sep; 66(3):147-52. PubMed ID: 12384201
    [Abstract] [Full Text] [Related]

  • 16. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity.
    Sullivan H, Furniss H, Spona J, Elstein M.
    Fertil Steril; 1999 Jul; 72(1):115-20. PubMed ID: 10428158
    [Abstract] [Full Text] [Related]

  • 17. Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition.
    Mulders TM, Dieben TO.
    Fertil Steril; 2001 May; 75(5):865-70. PubMed ID: 11334895
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
    Portman DJ, Kaunitz AM, Howard B, Weiss H, Hsieh J, Ricciotti N.
    Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
    [Abstract] [Full Text] [Related]

  • 19. Ortho Evra/Evra versus oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error.
    Pierson RA, Archer DF, Moreau M, Shangold GA, Fisher AC, Creasy GW.
    Fertil Steril; 2003 Jul; 80(1):34-42. PubMed ID: 12849799
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.
    Spona J, Feichtinger W, Kindermann C, Wünsch C, Brill K.
    Contraception; 1996 Nov; 54(5):299-304. PubMed ID: 8934064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.